Nucala (mepolizumab) approved in China for use in adults with chronic obstructive pulmonary disease (COPD)

Nucala (mepolizumab) approved in China for use in adults with chronic obstructive pulmonary disease (COPD)
Nucala is the first and only monthly biologic approved in China studied in a wide COPD population

Take Your Experience to the Next Level

New

Download our mobile app for a faster and better experience.

Google Play
App Store

Comments

0
U

Join the discussion

Sign in to leave a comment

0:000:00